Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 63 entries
Sorted by: Best Match Show Resources per page
Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study.

Stem cells international

Kastrup J, Schou M, Gustafsson I, Nielsen OW, Møgelvang R, Kofoed KF, Kragelund C, Hove JD, Fabricius-Bjerre A, Heitman M, Haack-Sørensen M, Lund LD, Johansen EM, Qayyum AA, Mathiasen AB, Ekblond A.
PMID: 29056973
Stem Cells Int. 2017;2017:8506370. doi: 10.1155/2017/8506370. Epub 2017 Sep 19.

BACKGROUND: Ischemic heart failure (IHF) has a poor prognosis in spite of optimal therapy. We have established a new allogeneic Cardiology Stem Cell Centre adipose-derived stromal cell (CSCC_ASC) product from healthy donors. It is produced without animal products, in...

Cite
Kastrup J, Schou M, Gustafsson I, et al. Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study. Stem Cells Int. 2017;2017:8506370doi: 10.1155/2017/8506370.
Kastrup, J., Schou, M., Gustafsson, I., Nielsen, O. W., Møgelvang, R., Kofoed, K. F., Kragelund, C., Hove, J. D., Fabricius-Bjerre, A., Heitman, M., Haack-Sørensen, M., Lund, L. D., Johansen, E. M., Qayyum, A. A., Mathiasen, A. B., & Ekblond, A. (2017). Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study. Stem cells international, 20178506370. https://doi.org/10.1155/2017/8506370
Kastrup, Jens, et al. "Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study." Stem cells international vol. 2017 (2017): 8506370. doi: https://doi.org/10.1155/2017/8506370
Kastrup J, Schou M, Gustafsson I, Nielsen OW, Møgelvang R, Kofoed KF, Kragelund C, Hove JD, Fabricius-Bjerre A, Heitman M, Haack-Sørensen M, Lund LD, Johansen EM, Qayyum AA, Mathiasen AB, Ekblond A. Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study. Stem Cells Int. 2017;2017:8506370. doi: 10.1155/2017/8506370. Epub 2017 Sep 19. PMID: 29056973; PMCID: PMC5625749.
Copy Download .nbib Format: NLM
Elevated circulating angiogenic progenitors and white blood cells are associated with hypoxia-inducible angiogenic growth factors in children with sickle cell disease.

Anemia

Ofori-Acquah SF, Buchanan ID, Osunkwo I, Manlove-Simmons J, Lawal F, Quarshie A, Quyyumi AA, Gibbons GH, Gee BE.
PMID: 22675614
Anemia. 2012;2012:156598. doi: 10.1155/2012/156598. Epub 2012 May 23.

We studied the number and function of angiogenic progenitor cells and growth factors in children aged 5-18 years without acute illness, 43 with Hemoglobin SS and 68 with normal hemoglobin. Hemoglobin SS subjects had at least twice as many...

Cite
Ofori-Acquah SF, Buchanan ID, Osunkwo I, et al. Elevated circulating angiogenic progenitors and white blood cells are associated with hypoxia-inducible angiogenic growth factors in children with sickle cell disease. Anemia. 2012;2012:156598doi: 10.1155/2012/156598.
Ofori-Acquah, S. F., Buchanan, I. D., Osunkwo, I., Manlove-Simmons, J., Lawal, F., Quarshie, A., Quyyumi, A. A., Gibbons, G. H., & Gee, B. E. (2012). Elevated circulating angiogenic progenitors and white blood cells are associated with hypoxia-inducible angiogenic growth factors in children with sickle cell disease. Anemia, 2012156598. https://doi.org/10.1155/2012/156598
Ofori-Acquah, Solomon F, et al. "Elevated circulating angiogenic progenitors and white blood cells are associated with hypoxia-inducible angiogenic growth factors in children with sickle cell disease." Anemia vol. 2012 (2012): 156598. doi: https://doi.org/10.1155/2012/156598
Ofori-Acquah SF, Buchanan ID, Osunkwo I, Manlove-Simmons J, Lawal F, Quarshie A, Quyyumi AA, Gibbons GH, Gee BE. Elevated circulating angiogenic progenitors and white blood cells are associated with hypoxia-inducible angiogenic growth factors in children with sickle cell disease. Anemia. 2012;2012:156598. doi: 10.1155/2012/156598. Epub 2012 May 23. PMID: 22675614; PMCID: PMC3366209.
Copy Download .nbib Format: NLM
Renin-Angiotensin System Blockade is Associated with Exercise Capacity, Sympathetic Activity and Endothelial Function in Patients with Chronic Kidney Disease.

Kidney & blood pressure research

Jeong JH, Sprick JD, DaCosta D, Quyyumi AA, Park J.
PMID: 34758473
Kidney Blood Press Res. 2021 Nov 10; doi: 10.1159/000520760. Epub 2021 Nov 10.

BACKGROUND: Chronic kidney disease (CKD) patients have exercise intolerance and exaggerated blood pressure reactivity during exercise that are mediated by sympathetic nervous system (SNS) overactivation and decreased nitric oxide (NO) bioavailability. Activation of the renin-angiotensin system (RAS) increases SNS...

Cite
Jeong JH, Sprick JD, DaCosta D, et al. Renin-Angiotensin System Blockade is Associated with Exercise Capacity, Sympathetic Activity and Endothelial Function in Patients with Chronic Kidney Disease. Kidney Blood Press Res. 2021;doi: 10.1159/000520760.
Jeong, J. H., Sprick, J. D., DaCosta, D., Quyyumi, A. A., & Park, J. (2021). Renin-Angiotensin System Blockade is Associated with Exercise Capacity, Sympathetic Activity and Endothelial Function in Patients with Chronic Kidney Disease. Kidney & blood pressure research, . https://doi.org/10.1159/000520760
Jeong, Jin Hee, et al. "Renin-Angiotensin System Blockade is Associated with Exercise Capacity, Sympathetic Activity and Endothelial Function in Patients with Chronic Kidney Disease." Kidney & blood pressure research vol. (2021). doi: https://doi.org/10.1159/000520760
Jeong JH, Sprick JD, DaCosta D, Quyyumi AA, Park J. Renin-Angiotensin System Blockade is Associated with Exercise Capacity, Sympathetic Activity and Endothelial Function in Patients with Chronic Kidney Disease. Kidney Blood Press Res. 2021 Nov 10; doi: 10.1159/000520760. Epub 2021 Nov 10. PMID: 34758473.
Copy Download .nbib Format: NLM
Cardiovascular disease risk and pathophysiology in South Asians: can longitudinal multi-omics shed light?.

Wellcome open research

Sun YV, Liu C, Staimez L, Ali MK, Chang H, Kondal D, Patel S, Jones D, Mohan V, Tandon N, Prabhakaran D, Quyyumi AA, Narayan KMV, Agrawal A.
PMID: 34136649
Wellcome Open Res. 2021 May 20;5:255. doi: 10.12688/wellcomeopenres.16336.2. eCollection 2020.

Cardiovascular disease (CVD) is the leading cause of mortality in South Asia, with rapidly increasing prevalence of hypertension, type 2 diabetes (T2DM) and hyperlipidemia over the last two decades. Atherosclerotic CVD (ASCVD) affects South Asians earlier in life and...

Cite
Sun YV, Liu C, Staimez L, et al. Cardiovascular disease risk and pathophysiology in South Asians: can longitudinal multi-omics shed light?. Wellcome Open Res. 2021;5:255doi: 10.12688/wellcomeopenres.16336.2.
Sun, Y. V., Liu, C., Staimez, L., Ali, M. K., Chang, H., Kondal, D., Patel, S., Jones, D., Mohan, V., Tandon, N., Prabhakaran, D., Quyyumi, A. A., Narayan, K. M. V., & Agrawal, A. (2020). Cardiovascular disease risk and pathophysiology in South Asians: can longitudinal multi-omics shed light?. Wellcome open research, 5255. https://doi.org/10.12688/wellcomeopenres.16336.2
Sun, Yan V, et al. "Cardiovascular disease risk and pathophysiology in South Asians: can longitudinal multi-omics shed light?." Wellcome open research vol. 5 (2020): 255. doi: https://doi.org/10.12688/wellcomeopenres.16336.2
Sun YV, Liu C, Staimez L, Ali MK, Chang H, Kondal D, Patel S, Jones D, Mohan V, Tandon N, Prabhakaran D, Quyyumi AA, Narayan KMV, Agrawal A. Cardiovascular disease risk and pathophysiology in South Asians: can longitudinal multi-omics shed light?. Wellcome Open Res. 2021 May 20;5:255. doi: 10.12688/wellcomeopenres.16336.2. eCollection 2020. PMID: 34136649; PMCID: PMC8176264.
Copy Download .nbib Format: NLM
Highly elevated polygenic risk scores are better predictors of myocardial infarction risk early in life than later.

Genome medicine

Isgut M, Sun J, Quyyumi AA, Gibson G.
PMID: 33509272
Genome Med. 2021 Jan 28;13(1):13. doi: 10.1186/s13073-021-00828-8.

BACKGROUND: Several polygenic risk scores (PRS) have been developed for cardiovascular risk prediction, but the additive value of including PRS together with conventional risk factors for risk prediction is questionable. This study assesses the clinical utility of including four...

Cite
Isgut M, Sun J, Quyyumi AA, et al. Highly elevated polygenic risk scores are better predictors of myocardial infarction risk early in life than later. Genome Med. 2021;13(1):13doi: 10.1186/s13073-021-00828-8.
Isgut, M., Sun, J., Quyyumi, A. A., & Gibson, G. (2021). Highly elevated polygenic risk scores are better predictors of myocardial infarction risk early in life than later. Genome medicine, 13(1), 13. https://doi.org/10.1186/s13073-021-00828-8
Isgut, Monica, et al. "Highly elevated polygenic risk scores are better predictors of myocardial infarction risk early in life than later." Genome medicine vol. 13,1 (2021): 13. doi: https://doi.org/10.1186/s13073-021-00828-8
Isgut M, Sun J, Quyyumi AA, Gibson G. Highly elevated polygenic risk scores are better predictors of myocardial infarction risk early in life than later. Genome Med. 2021 Jan 28;13(1):13. doi: 10.1186/s13073-021-00828-8. PMID: 33509272; PMCID: PMC7845089.
Copy Download .nbib Format: NLM
Neighborhood characteristics and ideal cardiovascular health among Black adults: results from the Morehouse-Emory Cardiovascular (MECA) Center for Health Equity.

Annals of epidemiology

Islam SJ, Kim JH, Baltrus P, Topel ML, Liu C, Ko YA, Mujahid MS, Vaccarino V, Sims M, Mubasher M, Khan A, Ejaz K, Searles C, Dunbar S, Pemu P, Taylor HA, Quyyumi AA, Lewis TT.
PMID: 33285258
Ann Epidemiol. 2022 Jan;65:120.e1-120.e10. doi: 10.1016/j.annepidem.2020.11.009. Epub 2020 Dec 05.

PURPOSE: Neighborhood environment is increasingly recognized as an important determinant of cardiovascular health (CVH) among Black adults. Most research to date has focused on negative aspects of the neighborhood environment, with little attention being paid to the specific positive...

Cite
Islam SJ, Kim JH, Baltrus P, et al. Neighborhood characteristics and ideal cardiovascular health among Black adults: results from the Morehouse-Emory Cardiovascular (MECA) Center for Health Equity. Ann Epidemiol. 2020;65:120.e1-120.e10doi: 10.1016/j.annepidem.2020.11.009.
Islam, S. J., Kim, J. H., Baltrus, P., Topel, M. L., Liu, C., Ko, Y. A., Mujahid, M. S., Vaccarino, V., Sims, M., Mubasher, M., Khan, A., Ejaz, K., Searles, C., Dunbar, S., Pemu, P., Taylor, H. A., Quyyumi, A. A., & Lewis, T. T. (2022). Neighborhood characteristics and ideal cardiovascular health among Black adults: results from the Morehouse-Emory Cardiovascular (MECA) Center for Health Equity. Annals of epidemiology, 65120.e1-120.e10. https://doi.org/10.1016/j.annepidem.2020.11.009
Islam, Shabatun J, et al. "Neighborhood characteristics and ideal cardiovascular health among Black adults: results from the Morehouse-Emory Cardiovascular (MECA) Center for Health Equity." Annals of epidemiology vol. 65 (2022): 120.e1-120.e10. doi: https://doi.org/10.1016/j.annepidem.2020.11.009
Islam SJ, Kim JH, Baltrus P, Topel ML, Liu C, Ko YA, Mujahid MS, Vaccarino V, Sims M, Mubasher M, Khan A, Ejaz K, Searles C, Dunbar S, Pemu P, Taylor HA, Quyyumi AA, Lewis TT. Neighborhood characteristics and ideal cardiovascular health among Black adults: results from the Morehouse-Emory Cardiovascular (MECA) Center for Health Equity. Ann Epidemiol. 2022 Jan;65:120.e1-120.e10. doi: 10.1016/j.annepidem.2020.11.009. Epub 2020 Dec 05. PMID: 33285258; PMCID: PMC8178422.
Copy Download .nbib Format: NLM
Association between race and maladaptive concentric left ventricular hypertrophy in American-style football athletes.

British journal of sports medicine

Tso JV, Turner CG, Liu C, Galante A, Gilson CR, Clark C, Taylor HA, Quyyumi AA, Baggish AL, Kim JH.
PMID: 34389546
Br J Sports Med. 2021 Aug 13; doi: 10.1136/bjsports-2021-104333. Epub 2021 Aug 13.

OBJECTIVES: American-style football (ASF) athletes are at risk for the development of concentric left ventricular hypertrophy (C-LVH), an established cardiovascular risk factor in the general population. We sought to address whether black race is associated with acquired C-LVH in...

Cite
Tso JV, Turner CG, Liu C, et al. Association between race and maladaptive concentric left ventricular hypertrophy in American-style football athletes. Br J Sports Med. 2021;doi: 10.1136/bjsports-2021-104333.
Tso, J. V., Turner, C. G., Liu, C., Galante, A., Gilson, C. R., Clark, C., Taylor, H. A., Quyyumi, A. A., Baggish, A. L., & Kim, J. H. (2021). Association between race and maladaptive concentric left ventricular hypertrophy in American-style football athletes. British journal of sports medicine, . https://doi.org/10.1136/bjsports-2021-104333
Tso, Jason V, et al. "Association between race and maladaptive concentric left ventricular hypertrophy in American-style football athletes." British journal of sports medicine vol. (2021). doi: https://doi.org/10.1136/bjsports-2021-104333
Tso JV, Turner CG, Liu C, Galante A, Gilson CR, Clark C, Taylor HA, Quyyumi AA, Baggish AL, Kim JH. Association between race and maladaptive concentric left ventricular hypertrophy in American-style football athletes. Br J Sports Med. 2021 Aug 13; doi: 10.1136/bjsports-2021-104333. Epub 2021 Aug 13. PMID: 34389546.
Copy Download .nbib Format: NLM
Racial Disparities in Adverse Cardiovascular Outcomes After a Myocardial Infarction in Young or Middle-Aged Patients.

Journal of the American Heart Association

Garcia M, Almuwaqqat Z, Moazzami K, Young A, Lima BB, Sullivan S, Kaseer B, Lewis TT, Hammadah M, Levantsevych O, Elon L, Bremner JD, Raggi P, Shah AJ, Quyyumi AA, Vaccarino V.
PMID: 34431313
J Am Heart Assoc. 2021 Sep 07;10(17):e020828. doi: 10.1161/JAHA.121.020828. Epub 2021 Aug 25.

Background Black patients tend to develop coronary artery disease at a younger age than other groups. Previous data on racial disparities in outcomes of myocardial infarction (MI) have been inconsistent and limited to older populations. Our objective was to...

Cite
Garcia M, Almuwaqqat Z, Moazzami K, et al. Racial Disparities in Adverse Cardiovascular Outcomes After a Myocardial Infarction in Young or Middle-Aged Patients. J Am Heart Assoc. 2021;10(17):e020828doi: 10.1161/JAHA.121.020828.
Garcia, M., Almuwaqqat, Z., Moazzami, K., Young, A., Lima, B. B., Sullivan, S., Kaseer, B., Lewis, T. T., Hammadah, M., Levantsevych, O., Elon, L., Bremner, J. D., Raggi, P., Shah, A. J., Quyyumi, A. A., & Vaccarino, V. (2021). Racial Disparities in Adverse Cardiovascular Outcomes After a Myocardial Infarction in Young or Middle-Aged Patients. Journal of the American Heart Association, 10(17), e020828. https://doi.org/10.1161/JAHA.121.020828
Garcia, Mariana, et al. "Racial Disparities in Adverse Cardiovascular Outcomes After a Myocardial Infarction in Young or Middle-Aged Patients." Journal of the American Heart Association vol. 10,17 (2021): e020828. doi: https://doi.org/10.1161/JAHA.121.020828
Garcia M, Almuwaqqat Z, Moazzami K, Young A, Lima BB, Sullivan S, Kaseer B, Lewis TT, Hammadah M, Levantsevych O, Elon L, Bremner JD, Raggi P, Shah AJ, Quyyumi AA, Vaccarino V. Racial Disparities in Adverse Cardiovascular Outcomes After a Myocardial Infarction in Young or Middle-Aged Patients. J Am Heart Assoc. 2021 Sep 07;10(17):e020828. doi: 10.1161/JAHA.121.020828. Epub 2021 Aug 25. PMID: 34431313.
Copy Download .nbib Format: NLM
Circulating Progenitor Cells in Patients With Coronary Artery Disease and Renal Insufficiency.

JACC. Basic to translational science

Mehta A, Tahhan AS, Liu C, Dhindsa DS, Nayak A, Hooda A, Moazzami K, Islam SJ, Rogers SC, Almuwaqqat Z, Mokhtari A, Hesaroieh I, Ko YA, Waller EK, Quyyumi AA.
PMID: 32875168
JACC Basic Transl Sci. 2020 Aug 12;5(8):770-782. doi: 10.1016/j.jacbts.2020.06.006. eCollection 2020 Aug.

Patients with coronary artery disease and renal insufficiency (RI) (estimated glomerular filtration rate 

Cite
Mehta A, Tahhan AS, Liu C, et al. Circulating Progenitor Cells in Patients With Coronary Artery Disease and Renal Insufficiency. JACC Basic Transl Sci. 2020;5(8):770-782doi: 10.1016/j.jacbts.2020.06.006.
Mehta, A., Tahhan, A. S., Liu, C., Dhindsa, D. S., Nayak, A., Hooda, A., Moazzami, K., Islam, S. J., Rogers, S. C., Almuwaqqat, Z., Mokhtari, A., Hesaroieh, I., Ko, Y. A., Waller, E. K., & Quyyumi, A. A. (2020). Circulating Progenitor Cells in Patients With Coronary Artery Disease and Renal Insufficiency. JACC. Basic to translational science, 5(8), 770-782. https://doi.org/10.1016/j.jacbts.2020.06.006
Mehta, Anurag, et al. "Circulating Progenitor Cells in Patients With Coronary Artery Disease and Renal Insufficiency." JACC. Basic to translational science vol. 5,8 (2020): 770-782. doi: https://doi.org/10.1016/j.jacbts.2020.06.006
Mehta A, Tahhan AS, Liu C, Dhindsa DS, Nayak A, Hooda A, Moazzami K, Islam SJ, Rogers SC, Almuwaqqat Z, Mokhtari A, Hesaroieh I, Ko YA, Waller EK, Quyyumi AA. Circulating Progenitor Cells in Patients With Coronary Artery Disease and Renal Insufficiency. JACC Basic Transl Sci. 2020 Aug 12;5(8):770-782. doi: 10.1016/j.jacbts.2020.06.006. eCollection 2020 Aug. PMID: 32875168; PMCID: PMC7452291.
Copy Download .nbib Format: NLM
Association of coronary wall shear stress with atherosclerotic plaque burden, composition, and distribution in patients with coronary artery disease.

Journal of the American Heart Association

Eshtehardi P, McDaniel MC, Suo J, Dhawan SS, Timmins LH, Binongo JN, Golub LJ, Corban MT, Finn AV, Oshinski JN, Quyyumi AA, Giddens DP, Samady H.
PMID: 23130168
J Am Heart Assoc. 2012 Aug;1(4):e002543. doi: 10.1161/JAHA.112.002543. Epub 2012 Aug 24.

BACKGROUND: Extremes of wall shear stress (WSS) have been associated with plaque progression and transformation, which has raised interest in the clinical assessment of WSS. We hypothesized that calculated coronary WSS is predicted only partially by luminal geometry and...

Cite
Eshtehardi P, McDaniel MC, Suo J, et al. Association of coronary wall shear stress with atherosclerotic plaque burden, composition, and distribution in patients with coronary artery disease. J Am Heart Assoc. 2012;1(4):e002543doi: 10.1161/JAHA.112.002543.
Eshtehardi, P., McDaniel, M. C., Suo, J., Dhawan, S. S., Timmins, L. H., Binongo, J. N., Golub, L. J., Corban, M. T., Finn, A. V., Oshinski, J. N., Quyyumi, A. A., Giddens, D. P., & Samady, H. (2012). Association of coronary wall shear stress with atherosclerotic plaque burden, composition, and distribution in patients with coronary artery disease. Journal of the American Heart Association, 1(4), e002543. https://doi.org/10.1161/JAHA.112.002543
Eshtehardi, Parham, et al. "Association of coronary wall shear stress with atherosclerotic plaque burden, composition, and distribution in patients with coronary artery disease." Journal of the American Heart Association vol. 1,4 (2012): e002543. doi: https://doi.org/10.1161/JAHA.112.002543
Eshtehardi P, McDaniel MC, Suo J, Dhawan SS, Timmins LH, Binongo JN, Golub LJ, Corban MT, Finn AV, Oshinski JN, Quyyumi AA, Giddens DP, Samady H. Association of coronary wall shear stress with atherosclerotic plaque burden, composition, and distribution in patients with coronary artery disease. J Am Heart Assoc. 2012 Aug;1(4):e002543. doi: 10.1161/JAHA.112.002543. Epub 2012 Aug 24. PMID: 23130168; PMCID: PMC3487351.
Copy Download .nbib Format: NLM
Endothelium-derived hyperpolarizing factor and vascular function.

Cardiology research and practice

Ozkor MA, Quyyumi AA.
PMID: 21876822
Cardiol Res Pract. 2011;2011:156146. doi: 10.4061/2011/156146. Epub 2011 Aug 15.

Endothelial function refers to a multitude of physiological processes that maintain healthy homeostasis of the vascular wall. Exposure of the endothelium to cardiac risk factors results in endothelial dysfunction and is associated with an alteration in the balance of...

Cite
Ozkor MA, Quyyumi AA. Endothelium-derived hyperpolarizing factor and vascular function. Cardiol Res Pract. 2011;2011:156146doi: 10.4061/2011/156146.
Ozkor, M. A., & Quyyumi, A. A. (2011). Endothelium-derived hyperpolarizing factor and vascular function. Cardiology research and practice, 2011156146. https://doi.org/10.4061/2011/156146
Ozkor, Muhiddin A, and Quyyumi, Arshed A. "Endothelium-derived hyperpolarizing factor and vascular function." Cardiology research and practice vol. 2011 (2011): 156146. doi: https://doi.org/10.4061/2011/156146
Ozkor MA, Quyyumi AA. Endothelium-derived hyperpolarizing factor and vascular function. Cardiol Res Pract. 2011;2011:156146. doi: 10.4061/2011/156146. Epub 2011 Aug 15. PMID: 21876822; PMCID: PMC3157651.
Copy Download .nbib Format: NLM
Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells.

Stem cells international

Poole JC, Quyyumi AA.
PMID: 23737803
Stem Cells Int. 2013;2013:658480. doi: 10.1155/2013/658480. Epub 2013 Apr 28.

ST elevation myocardial infarction (STEMI) is associated with an increased risk for congestive heart failure and long-term mortality despite the widespread use of thrombolysis and catheter-based revascularization. The need for improved post-STEMI therapies has led to a surge of...

Cite
Poole JC, Quyyumi AA. Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells. Stem Cells Int. 2013;2013:658480doi: 10.1155/2013/658480.
Poole, J. C., & Quyyumi, A. A. (2013). Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells. Stem cells international, 2013658480. https://doi.org/10.1155/2013/658480
Poole, Joseph C, and Quyyumi, Arshed A. "Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells." Stem cells international vol. 2013 (2013): 658480. doi: https://doi.org/10.1155/2013/658480
Poole JC, Quyyumi AA. Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells. Stem Cells Int. 2013;2013:658480. doi: 10.1155/2013/658480. Epub 2013 Apr 28. PMID: 23737803; PMCID: PMC3655659.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 63 entries